Fifth Chinese COVID-19 vaccine enters phase-3 clinical trials
Beijing: Chinese vaccine maker Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. has commenced the phase-3 clinical trials for its Covid-19 vaccine, ...
Read moreBeijing: Chinese vaccine maker Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. has commenced the phase-3 clinical trials for its Covid-19 vaccine, ...
Read moreBeijing: A phase 2 trial of a Covid-19 vaccine candidate conducted in China has found that the vaccine is safe ...
Read more
First it was Canada, and now Australia and Singapore: the anti-Trump factor appears to be benefiting parties that are perceived...
Read moreThe decision taken at a meeting of the Cabinet Committee on Political Affairs (CCPA), headed by Prime Minister Narendra Modi...
Read moreThrough the 1990s and up until fairly recently, India insisted on something called de-hyphenation. The hyphen referred to was the...
Read moreSeven years ago, the NSE International Exchange (NSE IX) was launched with much fanfare at GIFT City—India’s glittering bet on...
Read more